1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Doxorubicin Market – By Drug Formulation

1.3.2        Europe Doxorubicin Market – By Application

1.3.3        Europe Doxorubicin Market – By Distribution Channel

1.3.4        Europe Doxorubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Doxorubicin Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Doxorubicin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Increasing Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Potential Side-effects Associated with Doxorubicin

5.3         Market Opportunities

5.3.1        Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention

5.4         Future Trends

5.4.1        Increasing Approval of Generic Products

5.5         Impact Analysis

6.           Doxorubicin Market– Europe Analysis

6.1         Europe Doxorubicin Market Revenue Forecast and Analysis

7.           Europe Doxorubicin Market Analysis – By Drug Formulation

7.1         Overview

7.2         Europe Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)

7.3         Lyophilized Powder

7.3.1        Overview

7.3.2        Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

7.4         Doxorubicin Injection

7.4.1        Overview

7.4.2        Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.           Europe Doxorubicin Market Analysis – By Application

8.1         Overview

8.2         Europe Doxorubicin Market Share, By Application 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.4         Kidney Cancer

8.4.1        Overview

8.4.2        Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.5         Liver Cancer

8.5.1        Overview

8.5.2        Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.6         Sarcoma

8.6.1        Overview

8.6.2        Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.7         Ovarian Cancer

8.7.1        Overview

8.7.2        Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.8         Lung Cancer

8.8.1        Overview

8.8.2        Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.9         Leukemia

8.9.1        Overview

8.9.2        Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.10      Multiple Myeloma

8.10.1     Overview

8.10.2     Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.11      Others

8.11.1     Overview

8.11.2     Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.           Europe Doxorubicin Market Analysis – By Disribution Channel

9.1         Overview

9.2         Europe Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

10.        Europe Doxorubicin Market Analysis – By Country

10.1      Overview

10.1.1     Europe Doxorubicin Market, Revenue and Forecast to 2028, by Country (%)

10.1.1.1       UK Doxorubicin Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.1.1.1       UK Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.1.2       UK Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.1.3       UK Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.1.4       UK Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

10.1.1.2       Germany Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Germany Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.2.2       Germany Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.2.3       Germany Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.2.4       Germany Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

10.1.1.3       France Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       France Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.3.2       France Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.3.3       France Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.3.4       France Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

10.1.1.4       Italy Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1       Italy Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.4.2       Italy Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.4.3       Italy Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.4.4       Italy Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

10.1.1.5       Spain Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1       Spain Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.5.2       Spain Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.5.3       Spain Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.5.4       Spain Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

10.1.1.6       Rest of Europe Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1       Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

10.1.1.6.2       Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

10.1.1.6.3       Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

10.1.1.6.4       Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Accord Healthcare

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Cipla Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Meiji Holdings Co., Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Novartis AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pfizer Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Sun Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Baxter International Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Zydus Cadila

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Prevalence of Cancer (2020)

Table 3.             UK Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 4.             UK Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 5.             UK Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 6.             Germany Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 7.             Germany Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 8.             Germany Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 9.             France Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 10.          France Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 11.          France Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 12.          Italy Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 13.          Italy Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 14.          Italy Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 15.          Spain Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 16.          Spain Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 17.          Spain Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 18.          Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)

Table 19.          Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)

Table 20.          Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)

Table 21.          Organic Developments Done By Companies

Table 22.          Inorganic Developments Done by Companies

Table 23.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Doxorubicin Market Segmentation

Figure 2.           Europe Doxorubicin Market Segmentation, By Country

Figure 3.           Europe Doxorubicin Market Overview

Figure 4.           Europe Doxorubicin Market, By Drug Formulation

Figure 5.           Europe Doxorubicin Market, By Country

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Doxorubicin Market Impact Analysis Of Driver And Restraints

Figure 8.           Europe Doxorubicin Market– Revenue Forecast and Analysis

Figure 9.           Europe Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)

Figure 10.        Europe Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        Europe Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        Europe Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)

Figure 13.        Europe Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        Europe Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        Europe Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 16.        Europe Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        Europe Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        Europe Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        Europe Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        Europe Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 21.        Europe Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        Europe Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)

Figure 23.        Europe Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        Europe Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 25.        Europe Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 26.        Europe Doxorubicin Market, Revenue by Country (2022) (US$ Mn)

Figure 27.        Europe Doxorubicin Market, Revenue and Forecast to 2028, by Country (%)

Figure 28.        UK Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 29.        Germany Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 30.        France Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 31.        Italy Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 32.        Spain Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 33.        Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)